Company
Amedisys, Inc.
Headquarters: Baton Rouge, LA, United States
Founded: 1982
Employees: 21,000
CEO: Mr. Paul Berthold Kusserow
Market Cap
$3.04 Billion
USD as of Jan. 1, 2025
Amedisys, Inc. Categories
United States Healthcare Medical Care FacilitiesUnited States Healthcare United States Medical Care Facilities
Top Competitors by Market Capitalization
Industry: Medical Care Facilities
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $2.32 B |
| EBITDA | $286.9 M |
| Gross Profit TTM | $1.01 B |
| Profit Margin | 3.57% |
| Operating Margin | 8.00% |
| Quarterly Revenue Growth | 5.70% |
Stocks & Indices
Amedisys, Inc. has the following listings and related stock indices.
Stock: NASDAQ: AMED wb_incandescent
Stock: BMV: AMED wb_incandescent
Stock: FSX: ADY wb_incandescent
Key People
Founder(s): William F. Borne
Paul Kusserow (Chairman & CEO) Scott Ginn (CFO & E VP)